我們期待,成為全球醫藥保健的領航者“ Innovation, Breakthrough , Quality of Life for Health”
我們期待,成為全球醫藥保健的領航者“ Innovation, Breakthrough , Quality of Life for Health”

目前國鼎正針對癌症、自體免疫、神經退化、新陳代謝疾病與孤兒藥品等領域進行新藥研發,致力於在生命的每一階段增進人類的健康與福祉。
As a R&D Biotechnology Company, we are continuously searching and discovering new candidates and compounds for drug development through our rapid screening system and proprietary databank. Our next goals are to complete in-vivo studies, clinical trials, and to continue to protect our intellectual property through patents.

News
GoldenBiotech Antroquinonol Phase 2 NSCLC Clinical Study Presents Brilliant Results in ASCO Meeting.
Read More "News"
R&D Pipeline
We believe, expect and pioneer… “ Based on our ultimate spirit, GBC develops new drug candidates through our solid footstone and promotes health by promising...
Read More "R&D Pipeline"
PHARMACEUTICAL
The Mechanism of Action of Antroquinonol: Anti-Cancer Antroquinonol is to act as isoprenyltransferase inhibitor which indirectly blocks the prenylation of newly synthesized Ras and Ras-related...
Read More "PHARMACEUTICAL"

Golden Biotechnology Corporation (GBC), founded by Mr. Sheng Yung, Liu in 2002, is an leading and innovative drug discovery and evidence-based healthy food supplement manufacturing company dedicated to enhancing lives by developing high quality products that prevent and treat diseases.

GBC’s main focus is on new drug R&D, IP right, pharmacology, toxicology and clinical studies. GBC also has successfully built up the screening platforms to identify bioactive compounds from traditional Chinese herbal medicine that includes more than 480 kinds of local plants, 1300 species of fungi, mushrooms and seaweeds.

Throughout 2002-2005, around 400 drug candidates were obtained from these screening platforms. Based on our own core chemical database, the ubiquinone-like structure of Antroquinonol® was actually discovered in 2006 during drug development. The pharmacology and toxicology of Antroquinonol® have been established along with the CMC (Chemistry, Manufacturing, and Controls) development and large-scale cGMP manufacturing of Antroquinonol®.